Abstract | BACKGROUND: MATERIAL AND METHODS: This is a prospective study without randomization and control. The inclusion criteria were: infants (≤12 months) with tachyarrhythmia who failed to respond to first line drugs. Patients having post-surgical arrhythmias were excluded from the study. RESULTS: CONCLUSION: This small case series indicates that flecainide is an effective antiarrhythmic agent, free of side effects and when used orally is capable of terminating and controlling relatively resistant supraventricular tachycardia in children.
|
Authors | Vikas Kohli |
Journal | Indian heart journal
(Indian Heart J)
2013 Mar-Apr
Vol. 65
Issue 2
Pg. 168-71
ISSN: 0019-4832 [Print] India |
PMID | 23647896
(Publication Type: Journal Article)
|
Copyright | Copyright © 2013 Cardiological Society of India. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Anti-Arrhythmia Agents
- Flecainide
|
Topics |
- Administration, Oral
- Anti-Arrhythmia Agents
(therapeutic use)
- Flecainide
(therapeutic use)
- Humans
- Infant
- Prospective Studies
- Tachycardia, Atrioventricular Nodal Reentry
(drug therapy)
- Tachycardia, Ectopic Atrial
(drug therapy)
- Treatment Failure
|